Skip to content
Richard Peek
Richard Peek
  • Home
  • Contact Me
  • Publications
  • Richard Peek
← HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease
An unusual cause of abnormal weight loss →

Middle Tennessee Opioid Summit, “Understanding, Preventing and Treating Tennessee’s Opioid Epidemic,” is Oct. 22

Posted on October 8, 2019 by Gastroenterology Journal
This entry was posted in News. Bookmark the permalink.
← HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease
An unusual cause of abnormal weight loss →
  • Links

    • Gastroenterology
    • MyVUMC
  • October 2019
    S M T W T F S
     12345
    6789101112
    13141516171819
    20212223242526
    2728293031  
    « Sep   Nov »
  • Other websites

    • Etiological Studies of Gastric Carcinoma
    • H. pylori and Gastric Cancer
Richard Peek
Proudly powered by WordPress.